news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

the peak season for respiratory infections in autumn and winter is approaching, and vaccination of respiratory diseases has been launched in various places.

a reporter from the first financial daily learned from the shanghai center for disease control and prevention that after the highly anticipated new coronavirus vaccine is administered at one's own expense, stocks have been in place at shanghai's community health centers and prices have been clarified.

the reporter made an appointment for the fenglin vaccination clinic in xuhui district through the wechat applet health cloud. the covid-19 vaccine product displayed was sinocell's d-quadrivalent s protein xbb vaccine, and the price of a single dose was shown as 305.5 yuan at a self-paid fee. the earliest appointment for vaccination could be made this week. the reporter then called the vaccination department of the xinjing town community service center in changning district. the staff said that the covid-19 vaccine had just arrived, also produced by sinocell, and was currently accepting appointments for vaccination.

according to the shanghai center for disease control and prevention, the new coronavirus vaccine currently available in shanghai contains the xbb variant, which is a recombinant quadrivalent vaccine. the types of new coronavirus vaccines available for vaccination can be adjusted according to needs in the future.

according to the 2024 shanghai non-immunization program vaccine group procurement (supplement) announcement issued by the shanghai medical and health affairs service center, six covid-19 vaccines are listed, all of which contain xbb variant antigen components, one of which is an mrna technology route, and the other four are recombinant protein vaccines. in addition to the quadrivalent vaccine from sinocell, the other three are monovalent, bivalent, and trivalent vaccines, from zhifei bio, livzon pharmaceutical, and wisk bio.

the latest data released by the chinese center for disease control and prevention show that the new coronavirus has been continuously detected in influenza-like cases across the country recently, and the main prevalent strain is the omicron variant. for high-risk groups such as the elderly, people with underlying diseases, and people with weakened immune function, vaccination with the new coronavirus can reduce the risk of severe illness and death that may occur after infection.

according to the current national covid-19 vaccination policy, the target population for vaccination, vaccine selection, and vaccination intervals are still implemented in accordance with the current plan. for the target population that has completed basic immunization or has been infected with covid-19, one dose of vaccine containing xbb variant antigen components can be administered 3 to 6 months after the last vaccination or 6 months after the last infection (if both occur, the most recent one shall prevail). the specific vaccination procedures, priority recommendations, and actual supply of vaccine products for recipients of different ages, infection status, and previous immunization history shall be implemented in accordance with relevant national regulations.